Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

The EBV oncogene LMP1 protects lymphoma cells from cell death through the collagen-mediated activation of DDR1.

Cader FZ, Vockerodt M, Bose S, Nagy E, Brundler MA, Kearns P, Murray PG.

Blood. 2013 Dec 19;122(26):4237-45. doi: 10.1182/blood-2013-04-499004. Epub 2013 Oct 17.

2.

Activated DDR1 increases RS cell survival.

Carbone A, Gloghini A.

Blood. 2013 Dec 19;122(26):4152-4. doi: 10.1182/blood-2013-11-534123.

3.

Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.

Vockerodt M, Wei W, Nagy E, Prouzova Z, Schrader A, Kube D, Rowe M, Woodman CB, Murray PG.

J Pathol. 2013 Aug;230(4):399-409. doi: 10.1002/path.4198.

PMID:
23592216
4.
5.

The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis.

Carbone A, Gloghini A, Caruso A, De Paoli P, Dolcetti R.

Int J Cancer. 2017 Mar 15;140(6):1233-1245. doi: 10.1002/ijc.30473. Epub 2016 Oct 27. Review.

PMID:
27750386
6.

Analysis of a clonally related mantle cell and Hodgkin lymphoma indicates Epstein-Barr virus infection of a Hodgkin/Reed-Sternberg cell precursor in a germinal center.

Tinguely M, Rosenquist R, Sundström C, Amini RM, Küppers R, Hansmann ML, Bräuninger A.

Am J Surg Pathol. 2003 Nov;27(11):1483-8.

PMID:
14576485
7.
8.
9.

Pediatric Hodgkin lymphoma in a South Indian regional cancer center: its immunomorphology, tumor-associated macrophages, and association with Epstein-Barr virus.

Zameer MA, Premalata CS, Arunakumari B, Appaji L, Rao CR.

Pediatr Hematol Oncol. 2015 May;32(4):229-38. doi: 10.3109/08880018.2014.954071. Epub 2014 Sep 24.

PMID:
25252151
10.

STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma.

Kis LL, Gerasimcik N, Salamon D, Persson EK, Nagy N, Klein G, Severinson E, Klein E.

Blood. 2011 Jan 6;117(1):165-74. doi: 10.1182/blood-2010-01-265272. Epub 2010 Sep 27.

11.

Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.

De Leo A, Arena G, Stecca C, Raciti M, Mattia E.

Mol Cancer Res. 2011 Oct;9(10):1346-55. doi: 10.1158/1541-7786.MCR-11-0145. Epub 2011 Aug 19.

12.

Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology.

Knecht H, McQuain C, Martin J, Rothenberger S, Drexler HG, Berger C, Bachmann E, Kittler EL, Odermatt BF, Quesenberry PJ.

Oncogene. 1996 Sep 5;13(5):947-53.

PMID:
8806684
13.

[Molecular biological properties of the Epstein-Barr virus LMP1 gene: structure, function and polymorphism].

Smirnova KV, Diduk SV, Senyuta NB, Gurtsevitch VE.

Vopr Virusol. 2015;60(3):5-13. Review. Russian.

PMID:
26281300
14.

Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.

Skinnider BF, Elia AJ, Gascoyne RD, Patterson B, Trumper L, Kapp U, Mak TW.

Blood. 2002 Jan 15;99(2):618-26.

15.

Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells.

Flavell JR, Baumforth KR, Wood VH, Davies GL, Wei W, Reynolds GM, Morgan S, Boyce A, Kelly GL, Young LS, Murray PG.

Blood. 2008 Jan 1;111(1):292-301. Epub 2007 Aug 24.

16.

Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection.

Quintanilla-Martinez L, Fend F, Moguel LR, Spilove L, Beaty MW, Kingma DW, Raffeld M, Jaffe ES.

Am J Surg Pathol. 1999 Oct;23(10):1233-40.

PMID:
10524524
17.

The molecular mechanisms of classic Hodgkin's lymphoma.

Felberbaum RS.

Yale J Biol Med. 2005 Jul;78(4):203-10. Review.

20.

[Epstein-Barr Virus LMP1 oncogene variants in cell lines of different origin].

Yakovleva LS, Senyuta NB, Goncharova EV, Scherback LN, Smirnova RV, Pavlish OA, Gurtsevitch VE.

Mol Biol (Mosk). 2015 Sep-Oct;49(5):800-10. doi: 10.7868/S0026898415050213. Russian.

Supplemental Content

Support Center